blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1349841

EP1349841 - ANILINOPYRIMIDINE DERIVATIVES AS IKK INHIBITORS AND COMPOSITIONS AND METHODS RELATED THERETO [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.10.2010
Database last updated on 22.08.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): TR
published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Signal Pharmaceuticals, LLC
4550 Towne Centre Court
San Diego, CA 92121 / US
[2009/42]
Former [2003/41]For all designated states
SIGNAL PHARMACEUTICALS, INC.
5555 Oberlin Drive
San Diego, CA 92121 / US
Inventor(s)01 / KOIS, Adam
11363 Redbud Court
San Diego, CA 92127 / US
02 / MACFARLANE, Karen, J.
11435 Belshire Lane
San Diego, CA 92126 / US
03 / SATOH, Yoshitaka
11460 Larmier Circle
San Diego, CA 92131 / US
04 / BHAGWAT, Shripad, S.
5015 Ashley Falls Court
San Diego, CA 92130 / US
05 / PARNES, Jason, S.
12511 El Camino Real C
San Diego, CA 92139 / US
06 / PALANKI, Moorthy, S., S.
602 Crest Drive
Encinitas, CA 92024 / US
07 / ERDMAN, Paul, E.
8225 Jade Coast 93
San Diego, CA 92126 / US
 [2003/41]
Representative(s)Elend, Almut Susanne, et al
Venner Shipley LLP
406 Science Park
Milton Road
Cambridge CB4 0WW / GB
[N/P]
Former [2006/52]Elend, Almut Susanne, et al
Venner Shipley LLP Byron House Cambridge Business Park Cowley Road
Cambridge CB4 0WZ / GB
Former [2003/41]Jump, Timothy John Simon, et al
Venner Shipley & Co. 20 Little Britain
London EC1A 7DH / GB
Application number, filing date01999564.605.12.2001
[2003/41]
WO2001US46403
Priority number, dateUS20000251816P06.12.2000         Original published format: US 251816 P
[2003/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0246171
Date:13.06.2002
Language:EN
[2002/24]
Type: A2 Application without search report 
No.:EP1349841
Date:08.10.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 13.06.2002 takes the place of the publication of the European patent application.
[2003/41]
Type: B1 Patent specification 
No.:EP1349841
Date:02.12.2009
Language:EN
[2009/49]
Search report(s)International search report - published on:EP23.01.2003
ClassificationIPC:C07D239/42, C07D401/12, C07D405/12, C07D413/12, C07D403/12, A61K31/505, A61P29/00
[2003/41]
CPC:
C07D239/42 (EP,US); A61P1/04 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P13/12 (EP); A61P15/10 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P19/06 (EP); A61P19/10 (EP);
A61P25/00 (EP); A61P25/08 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P31/04 (EP);
A61P31/12 (EP); A61P31/14 (EP); A61P31/18 (EP);
A61P31/20 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P7/00 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); C07D401/12 (EP,US);
C07D403/12 (EP,US); C07D405/12 (EP,US); C07D413/12 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/41]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ANILINOPYRIMIDINDERIVATE ALS IKK?INHIBITOREN, UND HIERMIT IN ZUSAMMENHANG STEHENDE ZUSAMMENSETZUNGEN UND VERFAHREN[2003/41]
English:ANILINOPYRIMIDINE DERIVATIVES AS IKK INHIBITORS AND COMPOSITIONS AND METHODS RELATED THERETO[2003/41]
French:DERIVES D'ANILINOPYRIMIDINE UTILISES COMME INHIBITEURS DE KINASE I$G(K)B (IKK), COMPOSITIONS ET TECHNIQUES ASSOCIEES[2003/41]
Entry into regional phase07.07.2003National basic fee paid 
07.07.2003Designation fee(s) paid 
07.07.2003Examination fee paid 
Examination procedure03.07.2002Request for preliminary examination filed
International Preliminary Examining Authority: US
07.07.2003Examination requested  [2003/41]
29.09.2003Amendment by applicant (claims and/or description)
07.03.2007Despatch of a communication from the examining division (Time limit: M04)
16.07.2007Reply to a communication from the examining division
17.08.2007Despatch of a communication from the examining division (Time limit: M06)
24.01.2008Reply to a communication from the examining division
20.02.2008Despatch of a communication from the examining division (Time limit: M06)
03.12.2008Reply to a communication from the examining division
09.02.2009Communication of intention to grant the patent
24.07.2009Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
30.07.2009Fee for grant paid
30.07.2009Fee for publishing/printing paid
Opposition(s)03.09.2010No opposition filed within time limit [2010/45]
Request for further processing for:30.07.2009Request for further processing filed
30.07.2009Full payment received (date of receipt of payment)
Request granted
14.09.2009Decision despatched
The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
30.07.2009Request for further processing filed
30.07.2009Full payment received (date of receipt of payment)
Request granted
14.09.2009Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
03.12.2008Request for further processing filed
03.12.2008Full payment received (date of receipt of payment)
Request granted
17.12.2008Decision despatched
Fees paidRenewal fee
12.12.2003Renewal fee patent year 03
14.12.2004Renewal fee patent year 04
22.12.2005Renewal fee patent year 05
13.12.2006Renewal fee patent year 06
12.12.2007Renewal fee patent year 07
15.12.2008Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT02.12.2009
BE02.12.2009
CY02.12.2009
DK02.12.2009
FI02.12.2009
IT02.12.2009
NL02.12.2009
SE02.12.2009
TR02.12.2009
IE05.12.2009
LU05.12.2009
GR03.03.2010
ES13.03.2010
PT02.04.2010
MC01.07.2010
[2011/44]
Former [2011/21]AT02.12.2009
BE02.12.2009
CY02.12.2009
DK02.12.2009
FI02.12.2009
IT02.12.2009
NL02.12.2009
SE02.12.2009
IE05.12.2009
LU05.12.2009
GR03.03.2010
ES13.03.2010
PT02.04.2010
MC01.07.2010
Former [2011/14]AT02.12.2009
BE02.12.2009
CY02.12.2009
DK02.12.2009
FI02.12.2009
IT02.12.2009
NL02.12.2009
SE02.12.2009
IE05.12.2009
GR03.03.2010
ES13.03.2010
PT02.04.2010
MC01.07.2010
Former [2011/07]AT02.12.2009
BE02.12.2009
CY02.12.2009
DK02.12.2009
FI02.12.2009
NL02.12.2009
SE02.12.2009
IE05.12.2009
GR03.03.2010
ES13.03.2010
PT02.04.2010
MC01.07.2010
Former [2010/46]AT02.12.2009
BE02.12.2009
CY02.12.2009
FI02.12.2009
NL02.12.2009
SE02.12.2009
IE05.12.2009
GR03.03.2010
ES13.03.2010
PT02.04.2010
MC01.07.2010
Former [2010/37]AT02.12.2009
BE02.12.2009
CY02.12.2009
FI02.12.2009
NL02.12.2009
SE02.12.2009
ES13.03.2010
PT02.04.2010
MC01.07.2010
Former [2010/35]AT02.12.2009
CY02.12.2009
FI02.12.2009
NL02.12.2009
SE02.12.2009
ES13.03.2010
PT02.04.2010
MC01.07.2010
Former [2010/32]AT02.12.2009
CY02.12.2009
FI02.12.2009
SE02.12.2009
ES13.03.2010
Former [2010/30]AT02.12.2009
CY02.12.2009
FI02.12.2009
SE02.12.2009
Former [2010/25]CY02.12.2009
FI02.12.2009
SE02.12.2009
Former [2010/22]FI02.12.2009
SE02.12.2009
Cited inInternational search[A]WO9901439  (DU PONT PHARM CO [US]) [A] 1,11,38 * page 0; example 22; claim - *;
 [E]WO0246170  (SIGNAL PHARM INC [US]) [E] 1-38* the whole document *
ExaminationEP0233461
 WO9818782
 WO0112621
 WO0114375
 WO0220512
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.